801 related articles for article (PubMed ID: 19615544)
1. Transition from pemphigus foliaceus to bullous pemphigoid: intermolecular B-cell epitope spreading without IgG subclass shifting.
Recke A; Rose C; Schmidt E; Bröcker EB; Zillikens D; Sitaru C
J Am Acad Dermatol; 2009 Aug; 61(2):333-6. PubMed ID: 19615544
[TBL] [Abstract][Full Text] [Related]
2. Changes in the autoimmune blistering response: a clinical and immunopathological shift from pemphigus foliaceus to bullous pemphigoid.
Maeda JY; Moura AK; Maruta CW; Santi CG; Prisayanh PS; Aoki V
Clin Exp Dermatol; 2006 Sep; 31(5):653-5. PubMed ID: 16901304
[TBL] [Abstract][Full Text] [Related]
3. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
4. Coexistence of pemphigus vulgaris and bullous pemphigoid in the upper aerodigestive tract.
Tabuchi K; Nomura M; Murashita H; Fujisawa Y; Tsuji S; Okubo H; Hara A
Auris Nasus Larynx; 2006 Jun; 33(2):231-3. PubMed ID: 16168587
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of BAFF are increased in bullous pemphigoid but not in pemphigus vulgaris.
Asashima N; Fujimoto M; Watanabe R; Nakashima H; Yazawa N; Okochi H; Tamaki K
Br J Dermatol; 2006 Aug; 155(2):330-6. PubMed ID: 16882171
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
7. Clinical evidence of an intermolecular epitope spreading in a patient with pemphigus foliaceus converting into bullous pemphigoid.
Peterson JD; Chang AJ; Chan LS
Arch Dermatol; 2007 Feb; 143(2):272-4. PubMed ID: 17310017
[No Abstract] [Full Text] [Related]
8. Antibodies to desmogleins 1 and 3, but not to BP180, induce blisters in human skin grafted onto SCID mice.
Zillikens D; Schmidt E; Reimer S; Chimanovitch I; Hardt-Weinelt K; Rose C; Bröcker EB; Kock M; Boehncke WH
J Pathol; 2001 Jan; 193(1):117-24. PubMed ID: 11169524
[TBL] [Abstract][Full Text] [Related]
9. Combined features of pemphigus foliaceus and bullous pemphigoid: immunoblot and immunoelectron microscopic studies.
Ishiko A; Hashimoto T; Shimizu H; Masunaga T; Nishibori Y; Watanabe K; Nishikawa T
Arch Dermatol; 1995 Jun; 131(6):732-4. PubMed ID: 7778933
[No Abstract] [Full Text] [Related]
10. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
[TBL] [Abstract][Full Text] [Related]
11. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
Dainichi T; Chow Z; Kabashima K
J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin A antibodies against desmoglein 1, envoplakin, periplakin and BP230 in a patient with atypical bullous pemphigoid.
Yamaki F; Mayuzumi N; Ikeda S; Hashimoto T
J Dermatol; 2010 Mar; 37(3):255-8. PubMed ID: 20507390
[TBL] [Abstract][Full Text] [Related]
13. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading.
Fairley JA; Woodley DT; Chen M; Giudice GJ; Lin MS
J Am Acad Dermatol; 2004 Jul; 51(1):118-22. PubMed ID: 15243536
[TBL] [Abstract][Full Text] [Related]
14. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
15. Successful adjuvant treatment of severe bullous pemphigoid by tryptophan immunoadsorption.
Herrero-González JE; Sitaru C; Klinker E; Bröcker EB; Zillikens D
Clin Exp Dermatol; 2005 Sep; 30(5):519-22. PubMed ID: 16045683
[TBL] [Abstract][Full Text] [Related]
16. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS
J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928
[TBL] [Abstract][Full Text] [Related]
17. Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid.
Panko J; Florell SR; Hadley J; Zone J; Leiferman K; Vanderhooft S
J Am Acad Dermatol; 2009 Jun; 60(6):1057-62. PubMed ID: 19467379
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and classification of pemphigus and bullous pemphigoid.
Kershenovich R; Hodak E; Mimouni D
Autoimmun Rev; 2014; 13(4-5):477-81. PubMed ID: 24424192
[TBL] [Abstract][Full Text] [Related]
19. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous occurrence of anti-BP180 mucous membrane pemphigoid and mucosal-dominant pemphigus vulgaris.
Kobayashi K; Tanaka M; Nakajima S; Ito H; Harada T; Hashimoto T
Clin Exp Dermatol; 2009 Dec; 34(8):e785-8. PubMed ID: 19778312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
